Bruker Daltonics has announced the release of MALDI BioTyper™ system for the identification and classification of microorganisms using protein 'fingerprints' measured by MALDI-TOF mass spectrometry at ...

At the virtual ASMS 2020 Reboot conference, Bruker Corporation today announces a major advance in matrix-assisted laser desorption ionization (MALDI) with the launch of the world’s first ...

Innovative timsTOF platform combined with extreme MALDI PharmaPulse speed and robustness for unbiased, deep HTS and uHTS (ultra-high-throughput screening) Trapped Ion Mobility Spectrometry (TIMS ...

Bruker Corporation BRKR recently announced the launch of the neofleX Imaging Profiler for mass spectrometry-based tissue imaging at the 72nd ASMS meeting.The novel, high-performance MALDI-TOF/TOF ...

AMSTERDAM, April 15, 2019 /PRNewswire/ -- At the European Congress of Clinical Microbiology and Infectious Diseases (www.eccmid.org), Bruker announces new assays, software and library extensions ...

At the 4th Congress of European Microbiologists (Federation of European Microbiological Societies, or FEMS) meeting in Geneva, Bruker announces a coll ...

On Oct 9, we issued an updated research report on Bruker Corporation BRKR. The company’s recent acquisition and collaborations are a strategic fit. However, adverse currency fluctuations remain ...

Bruker introduces the novel timsTOF fleX™ mass spectrometer, which includes a software-switchable MALDI source adapted to the ESI timsTOF Pro™ platform. This new, combined ESI/MALDI capability ...

Bruker Corporation BRKR recently announced a collaboration and quality agreement with the medical device company, Accelerate Diagnostics Inc. AXDX. The agreement enables the validation of Bruker ...